Clinical Trial

Misoprostol Before Caesarean Section

Study acronym: Miso/CS
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 13, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-25; most recent amendment 2025-05-08.
Trial Details
NCT Number NCT06946914
Lead Sponsor Kafrelsheikh University
Conditions Misoprostol, Respiratory Distress Syndrome (RDS) of Neonate, Caesarean Section
Enrollment 160 participants
Start Date 2024-06-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-13